Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Start any new GLP-1 medication at the lowest available dose regardless of your previous tirzepatide dose
Adverse effects of incretin mimetics Potential adverse effects of incretin mimetics include: Hypoglycemia when taken with insulin GI distress Pancreatitis Renal insufficiency Possible risk of thyroid cancer Other non-insulin, injectable diabetes medications GIP/GLP-1 receptor co-agonists GIP/GLP-1 receptor co-agonists are used to treat type 2 diabetes only
Greden, J
[7] Con el vaciamiento gstrico retardado, estos alimentos permanecen en contacto con el revestimiento del estmago durante ms tiempo, lo que puede aumentar la probabilidad de malestar en personas sensibles
The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
Additionally, while our findings are reassuring with regard to effects on newborn birthweight, we will need to exclude any potential long-term impact on childhood metabolic health. For more information: Jacqueline Maya, MD , can be reached at [email protected].
